Jones Day is advising Astellas Pharma Inc. in its €800 million acquisition of Ogeda SA, a Belgian VC-backed drug discovery company Ogeda is a clinical-stage drug…
Astellas Pharma Inc.’s €800 million acquisition of Ogeda SA
Jones Day is advising Astellas Pharma Inc. in its €800 million acquisition of Ogeda SA, a Belgian VC-backed drug discovery company Ogeda is a clinical-stage drug…